Excessive adiposity has long been proved to be associated with greater incidence and mortality of breast cancer in post-menopausal women. However, the effects and underlying mechanisms of human adipocytes on breast cancer cells remain largely unknown. In recent years, several reports have revealed the oncogenic role of long non-coding RNA PVT1 in breast cancer. Here, we aimed to investigate the role and underlying mechanisms of PVT1 in triple-negative breast cancer (TNBC) cells cultured with mature adipogenic medium. At first, we successfully induced adipogenic differentiation from human adipose-derived mesenchymal stem cells and collected the mature adipogenic medium to mimic excessive adiposity. Our results demonstrated that the mature adipogenic medium promoted the epithelial-mesenchymal transition, enhanced the cell viability and migration potential of TNBC cells. In addition, we proved that mature adipogenic medium affected the PVT1 expression and inhibition of the PVT1 disturbed the role of mature adipogenic medium in TNBC cells. Finally, we illustrated that repression of p21 restored the phenotype caused by PVT1 knockdown in TNBC cells treated with mature adipogenic medium. Taken together, our results demonstrated that PVT1 affected the role of mature adipogenic medium in TNBC cells via modulating p21 expression.
Introduction
As one of the most common cancers and the major cause of cancer deaths among women, breast cancer causes a major public health problem worldwide [1] . Triple-negative breast cancer (TNBC), characterized as lacking expressions of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2), behaves the poorest prognosis and accounts for approximate 10%-20% of all breast cancer cases [2] . Patients with TNBC lack response to endocrine treatment or HER2 blockade [3] .
Thus, there is an urgent need to investigate the molecular mechanisms associated with TNBC to improve our current concepts for prevention and treatment of this disease.
Obesity has become an established risk factor for a variety of human diseases, such as cardiovascular diseases, diabetes and a variety of cancers [4, 5] . In breast cancer, adipose tissue is the main component of the tumor environment and displays an increase in several cellular processes including inflammation, hypoxia, angiogenesis, and the abnormal changes of endocrine factors, such as estrogen, insulin and so on [6] . Recent reports showed that overweight and obesity contributed to approximate 20% of all postmenopausal breast cancers. Although the role and underlying mechanisms of obesity in breast cancer risk are largely unknown, some researches demonstrated that adipocytes play an important role in breast cancer progression by modulation of the lipid transfer, the production of sex steroid hormones, androgen-to-estrogen production, insulin resistance and secretion of several adipokines [7, 8] . Walter et al. [9] investigated the secretome of cancer-associated adipose tissue (CAAT) explants from breast cancer patients and demonstrated that adipose stromal cells promoted the migration and invasion of breast cancer cells by secreting interleukin 6. However, the mechanisms of obesity in breast cancer are not fully understood.
In recent years, many long non-coding RNAs (lncRNAs) have been revealed. LncRNAs represent a class of evolutionarily conserved transcripts which are loosely defined as non-protein coding RNAs longer than 200 nucleotides [10, 11] . There are five classical biotypes of lncRNAs, including sense, antisense, bidirectional, intronic and intergenic [12] . Although once considered as transcriptional 'noise', lncRNAs attracted more and more attention for their important role in a variety of cellular processes, including growth, apoptosis, differentiation, cell cycle, homeostasis, development, and disease by regulating gene expression at different levels including transcription, RNA processing and transportation, and translation [13, 14] . More and more researches showed that lncRNAs play important roles in physical and pathological processes in various human diseases, such as cardiovascular diseases, circulatory system diseases, respiratory diseases, genitourinary system diseases, immune related diseases, neurodegenerative diseases, and cancers [15] [16] [17] [18] . Several lncRNAs play important roles in modulation of physical and pathological processes of breast cancer, such as MALAT1, UCA1, HOTAIR, HOTTIP, and NEAT1 [19] . However, the roles and underlying molecular mechanisms of lncRNAs in BC have not been well investigated.
The plasmacytoma variant translocation 1 gene (PVT1), which locates in the 8q24 gene desert, has been investigated as an oncogenic lncRNA in a variety of cancers, including nasopharyngeal carcinoma, colorectal cancer, lung cancer, renal cancer, pancreatic cancer, thyroid cancer, cervical cancer, prostate cancer, as well as breast cancer [20] [21] [22] . In recent years, researchers showed that PVT1 exerts important functions in tumor cell growth, cell migration and invasion in breast cancer. Yan et al. [23] demonstrated that the PVT1 absorbed the miR-1207-5p and promoted the proliferation by regulating the STAT6 expression in breast cancer cells. However, there has been no report about the role and underlying mechanism of PVT1 together with adipocytes in breast cancer.
Based on these findings, we hypothesized that adipocytes in breast cancer might affect the progress of breast cancer and PVT1 might be involved in this process. To test this hypothesis, we examined the expression, role and further, the underlying mechanisms of PVT1 in TNBC cells cultured with the mature adipogenic medium that mimics excessive adiposity.
Materials and methods

Cell culture
Cell lines MDA-MB-231, MDA-BA-468, and BT549 were maintained as recommended by the American Type Culture Collection (Manassas, USA). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, USA) supplemented with 10% fetal bovine serum (FBS), 100 μg/ml penicillin, 0.1 mg/ml streptomycin, and 2 mM L-glutamine. All cell lines were grown in a humidified atmosphere at 37°C containing 5% CO 2 .
Oil staining
Accumulation of intracellular fatty acids was visualized by Oil Red O staining (0.5% v/v; Sigma, St Louis, USA). Briefly, cells were washed with 1 × PBS for three times and then fixed with sodium cacodylate buffer for 4 h at 4°C. Cells were stained with Oil Red O solution (0.5% in 40% isopropanol) for 3 h at room temperature, and then washed twice with 40% isopropanol. Images of cells were captured with a phase contrast microscope (CKX53; Olympus, Tokyo, Japan).
RNA extraction and real-time PCR analysis
Total RNA was extracted using Trizol (Invitrogen) according to the manufacturer's protocol. Equal amounts of total RNA (1 μg) were used for reverse transcription using EasyScript One-Step gDNA Removal and cDNA Synthesis SuperMix (Transgen Biotech, Shanghai, China). Real-time PCR analyses were performed with the ABI PRISM 7500 Fast Real-Time PCR System (Applied Biosystems, Carlsbad, USA) and SYBR Green array (Donghuan Biotech, Shanghai, China). GAPDH was used as the internal control. Data was analyzed using the 2 −ΔΔCt method and arbitrary units were introduced to display the normalized relative gene expression levels. Primers used in qRT-PCR are as follows: PVT1, forward primer (F): 5′-TTGGCACATACAGCCATCAT-3′, and reverse primer (R): 5′-CAGTAAAAGGGGAACACCA-3′; p21, forward primer (F): 5′-GGCCACAGGCCAGCTTCCA-3′, and reverse primer (R): 5′-TGTGCACAACACCTGTGTC-′; and GAPDH, forward primer (F): 5′-CATGAGAAGTATGACAACAGCCT-3′, and reverse primer (R): 5′-AGTCCTTCCACGATACCAAAGT-3′.
Western blot analysis
Western blot analysis was carried out as previously described [24] . Briefly, cells were harvested, re-suspended in RIPA buffer containing protease inhibitors, and supernatants were loaded and separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Then, proteins were transferred from the gel to a polyvinylidene difluoride membrane (Millipore, Billerica, USA). All antibodies were used according to the manufacturer's introductions. Anti-N-cadherin (Ab76011), anti-E-cadherin (Ab40772), anti-vimentin (Ab92547), and anti-p21 (Ab109520) antibodies were purchased from Abcam (Cambridge, UK). The anti-GAPDH (rabbit, DH0261#) antibody was from Donghuan Biotech. Immunoreactivity was visualized using an Enhanced Chemiluminescence Detection kit (DH0101; Donghuan Biotech).
RNA interference and cell transfection
The RNAi oligonucleotides (siRNAs) specifically targeting PVT1 or p21 were designed and synthesized by GenePharma (Shanghai, China). The sequences of siRNAs were shown as follows: siPVT1-1: 5′-GGACAACAGUACACGCAUATT-3′; siPVT1-2: 5′-GCCACC UACAUUAAAGCUATT-3′. sip21-1: 5′-CUGCGAAGCUGAAGG AAAATT-3′; sip21-2: 5′-AUCACAGUGUUGUUAAUGUTT-3′; and sip21-3: 5′-CACAAACTGCCATTCAACAGGTATT-3′. siNC: 5′-CG UUCCACTCATUUCCACAGT-3′. The siRNAs duplexes were transfected into cells using Lipofectamine 2000 (Invitrogen) in Opti-MEM according to the manufacturer's protocol.
Cell viability assay
Cells were seeded in a 96-well plate at a density of 3000 cells per well and cell viability was measured using CCK8 cell proliferation kit (Donghuan Biotech) according to the manufacturer's instructions. Briefly, 10 μl reagents were added into each well and the plate was incubated at 37°C for 4 h. The optical density was measured at 570 nm using a microplate reader.
Cell migration assay
The migration potential of cells with different treatments was detected in vitro using a Transwell ® Chamber (Corning Co., Corning, USA). In brief, 5 × 10 4 cells re-suspended in serum-free medium were seeded in the upper chamber and 650 μl DMEM medium with 10% serum were added into lower chamber. After 18 h of culture, migrated cells were stained with 1% crystal violet for 15 min, air dried, photographed using a phase contrast microscope (CKX53), and counted in three random fields at 200 × magnification.
Statistical analysis
Data are presented as the mean ± standard error. Each experiment was repeated at least three times. The symbol * denotes a statistically significant difference (P < 0.05), while ** represents a highly significant difference (P < 0.01) in a two-tailed Student's t-test.
Results
Mature adipogenic medium promoted the TNBC cell EMT and enhanced the cell viability and cell migration potential
In order to determine the role of adipocytes in TNBC, we firstly induced the adipogenic differentiation from human adipose-derived mesenchymal stem cells (hADMSCs) using adipogenic differentiation medium for 4 weeks and used the Oil Red O staining to validate the efficiency of adipogenic differentiation. Oil Red O staining assay demonstrated that adipogenic differentiation was successfully induced from hADMSCs (Fig. 1A) . Then, mature adipogenic medium (MAM) was collected. Next, the three ER-negative breast cancer cell lines MDA-MB-231, MDA-MB-468 and BT549 were cultured with MAM or control medium (CM) and the results were analyzed by western blot analysis, CCK8 assay and cell migration assay. The results of western blot analysis showed a decrease in Ecadherin expression and an increase in N-cadherin and vimentin expression in MAM-cultured TNBC cells compared with the expression in the cells cultured with CM (Fig. 1B) , demonstrating that MAM promoted epithelial-mesenchymal transition (EMT) of TNBC cells. Furthermore, as shown in Fig. 1C,D , cell viability and migration potential were also promoted when TNBC cells were cultured in MAM.
MAM exerted its function in TNBC cells via modulating PVT1 expression
It has been reported that lncRNA PVT1 exerted important functions in tumor cell growth, cell migration and invasion in breast cancer [22] . To determine whether the PVT1 is involved in MAM-induced enhancement of EMT, cell viability and migration of TNBC cells, qRT-PCR assay was used to measure the expression of PVT1. The results of qRT-PCR showed that, compared with CM, MAM promoted PVT1 expression in TNBC cells ( Fig. 2A) . Given that MAM could regulate the PVT1 expression, we wondered whether the modulation of PVT1 could affect the role of MAM in TNBC cells.
To answer this question, we firstly designed siRNAs specific to PVT1 (siPVT1) and transfected them into MDA-MB-231 and BT549 cells. The results of qRT-PCR assay showed that the two PVT1 siRNAs could inhibit the expression of PVT1 effectively in the both cell lines (Fig. 2B,C) . We then detected whether the inhibition of PVT1 could affect the cellular processes of TNBC cells. Western blot analysis revealed an increase of E-cadherin expression and a decrease of N-cadherin and vimentin expression in TNBC cells transfected with siPVT1, compared with the cells transfected with control siRNA (Fig. 2D) . These results demonstrated that repression of PVT1 inhibited the EMT of TNBC cells. Furthermore, CCK8 assay showed that the repression of PVT1 inhibited the cell viability in TNBC cells (Fig. 2E) . Meanwhile, the cell migration potential of TNBC cells was also restrained after PVT1 was knockdown (Fig. 2F) . Taken together, these results demonstrated that PVT1 could be regulated by MAM and inhibition of PVT1 could affect the cellular processes of TNBC cells. We then wondered whether the role of MAM in TNBC cells is mediated by PVT1. To answer this question, MDA-MB-231 and BT549 cells were treated with MAM after transfection of siPVT1 or siNC, and then analyzed by western blot analysis, CCK8 assay and cell migration assay to detect the cellular processes. Indeed, repression of PVT1 reversed the promotion of EMT induced by MAM (Fig. 3A) . Furthermore, knockdown of PVT1 inhibited the enhancement of cell viability (Fig. 3B ) and migration potential (Fig. 3C ) in cells cultured with MAM. Taken together, these results suggested that PVT1 was involved in MAM-induced changes of cellular processes in TNBC cells.
p21 was regulated by PVT1 and inhibition of p21 affected the cellular processes in TNBC cells
A previous study demonstrated that PVT1 promotes EMT, cell proliferation and migration via inhibiting the p21 expression in pancreatic cancer cells [25] . We wondered whether the PVT1 plays its role via modulation of p21 expression in MAM-induced cellular processes in TNBC cells. To test this hypothesis, qPCR and western blot analysis were used to detect the p21 expression in MDA-MB-231 and BT549 cells transfected with siPVT1 or siNC, respectively. As shown in Fig. 4A ,B, inhibition of PVT1 promoted p21 expression at both mRNA level and protein level in MDA-MB-231 and BT549 cells.
We then designed siRNAs specific to p21 (sip21) and transfected them into MDA-MB-231 and BT549 cells. The results of qRT-PCR and western blot analysis showed that all the three p21 siRNAs could inhibit the expression of p21 effectively in these two cell lines (Fig. 4C,D) . We then detected whether the knockdown of p21 could affect the cellular processes of TNBC cells. Of note, western blot analysis showed a decrease of E-cadherin expression and an increase of N-cadherin and vimentin expression in TNBC cells transfected with sip21, compared with the expression in cells transfected with control siRNA (Fig. 4E) , demonstrating that repression of p21 promoted the EMT in TNBC cells. Furthermore, cell viability and migration potential were also significantly enhanced when p21 was knocked down (Fig. 4 F,G) . Taken together, these results demonstrated that p21 could be regulated by PVT1 and inhibition of p21 could affect the cellular processes of TNBC cells.
PVT1 exerted its function in TNBC cells via regulation of p21 expression
To further determine whether PVT1 exerts its function in TNBC cells treated with MAM via regulation of p21 expression, we firstly examined the p21 expression in MDA-MB-231 and BT549 cells treated with MAM and CM, respectively. Results showed that MAM inhibited the p21 expression in TNBC cells at both RNA level and protein level (Fig. 5A,B) . Then cells were treated with MAM after transfection of sip21 coupled with siPVT1 or siNC, and the cellular processes were tested. The results showed that sip21 inhibited the siPVT1-induced promotion of p21 in TNBC cells treated with MAM (Fig. 5C) . The results also showed that, while EMT of TNBC cells was restrained when PVT1 was inhibited, its level was restored if p21 was knocked down simultaneously (Fig. 5D) . Furthermore, repression of p21 partially restored the reduced cell viability and cell migration potential in TNBC cells induced by knockdown of PVT1 (Fig. 5E,F) . Taken together, these results suggested that PVT1 exerted its function in TNBC cells through regulating p21.
Discussion
As we all know, excessive adiposity is one of the most dominant risk factors for breast cancer. However, the interactions and underlying mechanisms between the adipocytes and breast cancer cells at the microenvironment level are complex and vague [26] . In the present study, we aimed to explore the role and mechanism of MAM that mimics excessive adiposity in TNBC cells. We confirmed that MAM promoted EMT, cell viability and migration potential of TNBC cells. Of note, we demonstrated that lncRNA PVT1 may participate in this process. In addition, we found that PVT1 may affect the role of MAM in TNBC cells via modulation of the p21 expression.
Over the past 20 years, a growing number of people are obesity epidemic. Obesity is associated with higher morbidity and mortality for a variety of cancers, including prostate cancer, colon cancer, kidney cancer, bladder cancer, hepatocellular carcinoma, as well as breast cancer [27, 28] . Obesity regulates the cancer cell proliferation, migration, and invasion, as well as in vivo tumorigenesis [29] . Almost 25% women suffer from breast cancer over their lifetime, making breast cancer as the most common cancer among women worldwide. In recent years, there are more and more epidemiological evidence supporting a correlation between higher risk of developing breast cancer and post-menopausal women [30] . Thus investigating the crosstalk between cellular processes and mature adipocytes in breast cancer is of great clinical importance. In this study, we found that the MAM promoted the EMT (Fig. 1B) , enhanced the cell viability (Fig. 1C) and cell migration potential (Fig. 1D ) of three TNBC cell lines. These results proved the role of MAM in TNBC cells.
The roles and underlying mechanisms of adipocytes in the tumor microenvironment are complex. Recently, researchers mainly focused on the role of secretions and basal role of the adipocytes and adipose tissue in tumor occurrence and development, including insulin resistance, chronic inflammation and inflammatory cytokines, adipokines, and sex hormones [30, 31] . It has been reported that small non-coding RNAs are involved in the functions of adipocytes in breast cancers [31, 32] .
LncRNAs are defined as transcripts longer than 200 nt lacking protein coding capacity. LncRNAs play important roles in a variety of human diseases, including the tumorigenesis and obesity [17] . LncRNAs affect several cellular processes to involve in the tumorigenesis, such as cell growth, cell apoptosis, cell cycle, cell differentiation, homeostasis at different levels [14] . Over the past several years, the role and underlying mechanisms of lncRNAs in adipogenesis has been extensively studied [33] . Xu et al. [34] expounded the first lncRNA playing roles in the adipogenesis. Their study demonstrated that the lncRNA SRA (steroid receptor RNA activator) enhanced adipogenesis and adipocyte function through multiple pathways. These results demonstrated that lncRNA played important roles in tumorigenesis of breast cancer and adipogenesis. However, there were rare documents about the role of lncRNAs in the interaction between obesity and breast cancer. In this study, we found that PVT1, a well-studied oncogenic lncRNAs, participated in the interaction between obesity and breast cancer ( Fig. 2A) . Knockdown of the PVT1 inhibited the MAM-induced promotion of EMT (Fig. 3A) , cell viability (Fig. 3B) and cell migration potential (Fig. 3C) of TNBC cells. Further investigation revealed that PVT1 modulated cell progress of TNBC through regulating p21.
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